Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
RTI Health Solutions
A+A Healthcare Marketing Research
Freelance CRA (FCRA)
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
1. First determined to have platinum-sensitive recurrent serous ovarian cancer between January 1, 2009, and December 31, 2013 (study entry period), as defined by no evidence of disease progression for at least 6 months after completion of a first-line platinum-based chemotherapy regimen; the first date of platinum-sensitive recurrence between January 1, 2009 and December 31, 2013 will define the study index date.
2. At least 18 years of age on the index date.
3. Fully documented medical history related to the patient's ovarian cancer treatment beginning with initial diagnosis of serous ovarian cancer.
4. Patients can be either alive or deceased at the time of medical record abstraction.
You may not be if
1\. Ever taken an investigational product as part of an interventional clinical trial for ovarian cancer.
Clareo Health | OSCA - Olaparib Standard of CAre Study
